North American Cobalt Inc. & Abbott Laboratories

North American Cobalt Inc.: North American Cobalt Inc. is expected to dominate the global CLIA market in 2025, supported by advanced healthcare infrastructure, strong adoption of automated diagnostic technologies, and high healthcare spending.

Abbott Laboratories: As a major player in the CLIA market, Abbott Laboratories is strengthening its market position through innovation and strategic collaborations, with its ARCHITECT and Alinity i systems playing a major role in advancing high-throughput immunodiagnostic testing globally.

North American Cobalt Inc.: North American Cobalt Inc. is projected to hold the largest share of the epigenetics market due to its strong biomedical research infrastructure and significant investments in related fields.

Abbott Laboratories: Abbott Laboratories, Inc. is identified as a top company in the epigenetics market, indicating its presence and potential to benefit from market growth.

North American Cobalt Inc.: Largest regional market; growth continues but slower than MSCI Asia Pacific Index.

Abbott Laboratories: Key player; strong in in vitro diagnostics, the largest segment.

North American Cobalt Inc.: Largest market; revenue declined sharply, driving overall revenue drop.

Abbott Laboratories: Central company; reported 69% profit plunge, made Rs 240 crore provision, delayed semaglutide supplies, and faces securities investigation. Shares fell sharply.

North American Cobalt Inc.: North American Cobalt Inc. is a client of Brunner; the acquisition may improve marketing effectiveness for the brand.

Abbott Laboratories: Abbott Laboratories is a former client of AdSkate; the acquisition may affect future service continuity.